Can positron emission tomography with the dual tracers [ 11C]acetate and [ 18F]fludeoxyglucose predict microvascular invasion in hepatocellular carcinoma?

Liver Transplantation

Volumn 17, Issue 10, 2011, Pages 1218-1225

  Cheung, Tan To ^a   Chan, See Ching ^a,b   Ho, Chi Lai ^c   Chok, Kenneth Siu Ho ^a   Chan, Albert Chi Yan ^a   Sharr, William Wei ^a   Ng, Kelvin Kwok Chai ^a   Poon, Ronnie Tung Ping ^a,b   Lo, Chung Mau ^a,b   Fan, Sheung Tat ^a,b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b THE UNIVERSITY OF HONG KONG   (Hong Kong)

^c HONG KONG SANATORIUM AND HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID C 11; FLUORODEOXYGLUCOSE F 18;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER INVASION; CANCER RECURRENCE; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; DISEASE FREE SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER NODULE; LIVER RESECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MICROVASCULAR INVASION; MICROVASCULATURE; OVERALL SURVIVAL; POORLY DIFFERENTIATED LIVER CELL CARCINOMA; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; SURVIVAL TIME; WHOLE BODY PET;

ACETATES; ADULT; AGED; AGED, 80 AND OVER; CARBON; CARCINOMA, HEPATOCELLULAR; CHI-SQUARE DISTRIBUTION; DISEASE-FREE SURVIVAL; FEMALE; FLUORODEOXYGLUCOSE F18; HEPATECTOMY; HONG KONG; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MICROVESSELS; MIDDLE AGED; NEOPLASM INVASIVENESS; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 80053291972     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.22362     Document Type: Article

References (35)

1. Bruix J, Sherman M,; for Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology 2005; 42: 1208-1236. (Pubitemid 43112690)
2. Fan ST,. Surgical therapy of hepatocellular carcinoma in the cirrhotic liver. Swiss Surg 1999; 5: 107-110. (Pubitemid 29274570)
3. Neuhaus P, Jonas S, Bechstein WO, Wex C, Kling N, Settmacher U, al-Abadi H,. Liver transplantation for hepatocellular carcinoma. Transplant Proc 1999; 31: 469-471. (Pubitemid 29128633)
4. Poon RT, Fan ST, Tsang FH, Wong J,. Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon's perspective. Ann Surg 2002; 235: 466-486. (Pubitemid 34258345)
5. Cheung TT, Ng KK, Poon RT, Fan ST,. Tolerance of radiofrequency ablation by patients of hepatocellular carcinoma. J Hepatobiliary Pancreat Surg 2009; 16: 655-660.
6. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334: 693-699. (Pubitemid 26079803)
7. Lo CM, Fan ST, Liu CL, Yong BH, Lai CL, Lau GK, et al. Ten-year experience with liver transplantation at Queen Mary Hospital: retrospective study. Hong Kong Med J 2002; 8: 240-244.
8. Ng KK, Lo CM, Chan SC, Chok KS, Cheung TT, Fan ST,. Liver transplantation for hepatocellular carcinoma: the Hong Kong experience. J Hepatobiliary Pancreat Surg 2010; 17: 548-554.
9. Regalia E, Coppa J, Pulvirenti A, Romito R, Schiavo M, Burgoa L, Mazzaferro V,. Liver transplantation for small hepatocellular carcinoma in cirrhosis: analysis of our experience. Transplant Proc 2001; 33: 1442-1444. (Pubitemid 32237918)
10. Mazzaferro V, Rondinara GF, Rossi G, Regalia E, De Carlis L, Caccamo L, et al. Milan multicenter experience in liver transplantation for hepatocellular carcinoma. Transplant Proc 1994; 26: 3557-3560.
11. Shah SA, Tan JC, McGilvray ID, Cattral MS, Levy GA, Greig PD, Grant DR,. Does microvascular invasion affect outcomes after liver transplantation for HCC? A histopathological analysis of 155 consecutive explants. J Gastrointest Surg 2007; 11: 464-471.
12. Sumie S, Kuromatsu R, Okuda K, Ando E, Takata A, Fukushima N, et al. Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors. Ann Surg Oncol 2008; 15: 1375-1382.
13. 18F-FDG-uptake of hepatocellular carcinoma on PET predicts microvascular tumor invasion in liver transplant patients. Am J Transplant 2009; 9: 592-600.
14. 18F-FDG PET in the detection of extrahepatic metastases from hepatocellular carcinoma. J Gastroenterol 2004; 39: 961-968. (Pubitemid 39490173)
15. Wolfort RM, Papillion PW, Turnage RH, Lillien DL, Ramaswamy MR, Zibari GB,. Role of FDG-PET in the evaluation and staging of hepatocellular carcinoma with comparison of tumor size, AFP level, and histologic grade. Int Surg 2010; 95: 67-75.
16. Huo L, Wu Z, Zhuang H, Fu Z, Dang Y,. Dual time point C-11 acetate PET imaging can potentially distinguish focal nodular hyperplasia from primary hepatocellular carcinoma. Clin Nucl Med 2009; 34: 874-877.
17. Ho CL, Chen S, Yeung DW, Cheng TK,. Dual-tracer PET/CT imaging in evaluation of metastatic hepatocellular carcinoma. J Nucl Med 2007; 48: 902-909. (Pubitemid 46909918)
18. 11C]acetate. Appl Radiat Isot 1992; 43: 943-945.
19. 11C-acetate PET imaging in hepatocellular carcinoma and other liver masses. J Nucl Med 2003; 44: 213-221.
20. Edmondson HA, Steiner PE,. Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer 1954; 7: 462-503.
21. Burrel M, Llovet JM, Ayuso C, Iglesias C, Sala M, Miquel R, et al.; for Barcelona Clínic Liver Cancer Group. MRI angiography is superior to helical CT for detection of HCC prior to liver transplantation: an explant correlation. Hepatology 2003; 38: 1034-1042. (Pubitemid 37221687)
22. Forner A, Vilana R, Ayuso C, Bianchi L, Solé M, Ayuso JR, et al. Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma. Hepatology 2008; 47: 97-104. (Pubitemid 351171046)
23. Rode A, Bancel B, Douek P, Chevallier M, Vilgrain V, Picaud G, et al. Small nodule detection in cirrhotic livers: evaluation with US, spiral CT, and MRI and correlation with pathologic examination of explanted liver. J Comput Assist Tomogr 2001; 25: 327-336. (Pubitemid 32440782)
24. de Lédinghen V, Laharie D, Lecesne R, Le Bail B, Winnock M, Bernard PH, et al. Detection of nodules in liver cirrhosis: spiral computed tomography or magnetic resonance imaging? A prospective study of 88 nodules in 34 patients. Eur J Gastroenterol Hepatol 2002; 14: 159-165. (Pubitemid 34163995)
25. Jonas S, Bechstein WO, Steinmüller T, Herrmann M, Radke C, Berg T, et al. Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology 2001; 33: 1080-1086. (Pubitemid 32378206)
26. Esnaola NF, Mirza N, Lauwers GY, Ikai I, Regimbeau JM, Belghiti J, et al. Comparison of clinicopathologic characteristics and outcomes after resection in patients with hepatocellular carcinoma treated in the United States, France, and Japan. Ann Surg 2003; 238: 711-719. (Pubitemid 38182263)
27. Takamori R, Wong LL, Dang C, Wong L,. Needle-tract implantation from hepatocellular cancer: is needle biopsy of the liver always necessary? Liver Transpl 2000; 6: 67-72. (Pubitemid 30123370)
28. Libbrecht L, Bielen D, Verslype C, Vanbeckevoort D, Pirenne J, Nevens F, et al. Focal lesions in cirrhotic explant livers: pathological evaluation and accuracy of pretransplantation imaging examinations. Liver Transpl 2002; 8: 749-761. (Pubitemid 35012282)
29. 18F-FDG-PET imaging for the selection of liver transplantation candidates among hepatocellular carcinoma patients. Liver Transpl 2006; 12: 1655-1660. (Pubitemid 44742545)
30. 18F-FDG PET in liver transplantation for hepatocellular carcinoma. J Nucl Med 2009; 50: 682-687.
31. 18F]FDG PET/CT. Eur J Nucl Med Mol Imaging 2006; 33: 1285-1289. (Pubitemid 44630783)
32. Enomoto K, Fukunaga T, Okazumi S, Asano T, Kikuchi T, Yamamoto H, et al. Can fluorodeoxyglucose-positron emission tomography evaluate the functional differentiation of hepatocellular carcinoma [in Japanese]. Kaku Igaku 1991; 28: 1353-1356.
33. 18F-fluorodeoxyglucose positron emission tomography in detecting extrahepatic metastasis in pretreatment staging of hepatocellular carcinoma. Oncology 2007; 72 (suppl 1): 104-110. (Pubitemid 350256673)
34. Yoshimoto M, Waki A, Yonekura Y, Sadato N, Murata T, Omata N, et al. Characterization of acetate metabolism in tumor cells in relation to cell proliferation: acetate metabolism in tumor cells. Nucl Med Biol 2001; 28: 117-122. (Pubitemid 32276075)
35. 11C-acetate uptake and cell survival in hepatocellular carcinoma. J Nucl Med 2009; 50: 1222-1228.